E386 | Stanislav Poslavsky (MiLaboratories) & Joachim Laqueur (Acrobator Ventures): The Founder–Investor Dynamic: Building MiLaboratories with Acrobator & KFund episode artwork

EPISODE · Dec 10, 2024 · 1H

E386 | Stanislav Poslavsky (MiLaboratories) & Joachim Laqueur (Acrobator Ventures): The Founder–Investor Dynamic: Building MiLaboratories with Acrobator & KFund

from EUVC · host EUVC

Welcome to a special episode of the EUVC podcast! This time, we’re experimenting with a new format where we bring together a founder and two of their key investors to uncover the dynamics behind building and scaling a venture-backed company.In this episode, we’re joined by Stanislav Poslavsky, CEO and Co-Founder of MiLaboratories, a US-based biotech company founded in 2021. Focused on providing innovative solutions for genomic research, MiLaboratories operates on a B2B revenue model, catering to bioinformaticians and biologists in academic and pharmaceutical settings across the US, EU, and UK.Joachim Laqueur, Founding Partner at Acrobator Ventures, a seed-stage investment firm with €28M in assets under management. Based in the Netherlands, Joachim specializes in backing global startups with a focus on Europe and the US, targeting B2B software and software-enabled hardware.Miguel Arias, General Partner at KFund, €225M early growth fund, with €650M in assets under management. Based in Spain, Miguel focuses on Series A and B investments across Southern Europe and Latin America, targeting enabling technologies such as AI, IoT, and digital infrastructure.Together, we explore how MiLaboratories secured its place in their portfolios, the process of building conviction across investment stages, and the unique challenges and opportunities of funding a biotech company in today’s landscape. Expect deep dives into deal-making dynamics, the art of company building, and even a few lighthearted moments that reveal the human side of venture capital.Go to eu.vc to read the core take-aways.Chapters:01:50 Journey: Founding MiLaboratories02:47 Joachim's Perspective: Investing in MiLaboratories04:05 The Early Fundraising Challenges05:30 The Role of COVID in Fundraising 07:45 Miguel's Introduction and Perspective10:08 Series A Fundraising Experience15:24 Lessons Learned in Fundraising19:46 Understanding MiLaboratories' Impact33:02 The Duality of Business Strategy33:13 Building a Sustainable Business34:23 The Power of Open Source35:48 Conviction in Venture Capital38:03 Choosing the Right Investors42:04 The Art of Pricing45:57 The CEO's Many Hats49:12 Understanding Platforma and MeXR53:35 Challenges and Lessons Learned57:47 The Future of MiLaboratories

Welcome to a special episode of the EUVC podcast! This time, we’re experimenting with a new format where we bring together a founder and two of their key investors to uncover the dynamics behind building and scaling a venture-backed company.In this episode, we’re joined by Stanislav Poslavsky, CEO and Co-Founder of MiLaboratories, a US-based biotech company founded in 2021. Focused on providing innovative solutions for genomic research, MiLaboratories operates on a B2B revenue model, catering to bioinformaticians and biologists in academic and pharmaceutical settings across the US, EU, and UK.Joachim Laqueur, Founding Partner at Acrobator Ventures, a seed-stage investment firm with €28M in assets under management. Based in the Netherlands, Joachim specializes in backing global startups with a focus on Europe and the US, targeting B2B software and software-enabled hardware.Miguel Arias, General Partner at KFund, €225M early growth fund, with €650M in assets under management. Based in Spain, Miguel focuses on Series A and B investments across Southern Europe and Latin America, targeting enabling technologies such as AI, IoT, and digital infrastructure.Together, we explore how MiLaboratories secured its place in their portfolios, the process of building conviction across investment stages, and the unique challenges and opportunities of funding a biotech company in today’s landscape. Expect deep dives into deal-making dynamics, the art of company building, and even a few lighthearted moments that reveal the human side of venture capital.Go to eu.vc to read the core take-aways.Chapters:01:50 Journey: Founding MiLaboratories02:47 Joachim's Perspective: Investing in MiLaboratories04:05 The Early Fundraising Challenges05:30 The Role of COVID in Fundraising 07:45 Miguel's Introduction and Perspective10:08 Series A Fundraising Experience15:24 Lessons Learned in Fundraising19:46 Understanding MiLaboratories' Impact33:02 The Duality of Business Strategy33:13 Building a Sustainable Business34:23 The Power of Open Source35:48 Conviction in Venture Capital38:03 Choosing the Right Investors42:04 The Art of Pricing45:57 The CEO's Many Hats49:12 Understanding Platforma and MeXR53:35 Challenges and Lessons Learned57:47 The Future of MiLaboratories

NOW PLAYING

E386 | Stanislav Poslavsky (MiLaboratories) & Joachim Laqueur (Acrobator Ventures): The Founder–Investor Dynamic: Building MiLaboratories with Acrobator & KFund

0:00 1:00:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EUVC?

This episode is 1 hour and 0 minutes long.

When was this EUVC episode published?

This episode was published on December 10, 2024.

What is this episode about?

Welcome to a special episode of the EUVC podcast! This time, we’re experimenting with a new format where we bring together a founder and two of their key investors to uncover the dynamics behind building and scaling a venture-backed company.In this...

Can I download this EUVC episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!